RAMP Scholars


HVTN Research and Mentorship Program (RAMP) Scholar Program for African American/Black and Latinx Medical Students

Applications for 2022-2023 are now open!

The HIV Vaccine Trials Network, in collaboration with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health is investing in the next generation of HIV prevention researchers by providing African American and Latinx medical students with opportunities for independent research along with structured mentoring, project and salary funding, training, and professional development activities.


Program Track for the 2022-2023 Cycle

Grant recipients will work under the mentorship of HVTN-affiliated investigators to conduct research projects in areas of basic, clinical, behavioral, laboratory and social science. Projects will be 8-10 weeks or 9-12 months (onsite portion).

Short-Term: 8-10 weeks

  • Can be timed with a summer break or fourth year research elective
  • Travel to an HIV Vaccine Clinical Research Site in the US or abroad (if COVID has been controlled)
  • Attend and present at an HVTN Conference
  • Maximum award of $20,000

Long-Term: 9-12 months

  • Research at an HIV Vaccine Clinical Research Site in the US or abroad (if COVID has been controlled)
  • Can be timed with a planned Master's or doctoral program, or be a distinct, non-degree associated research-focused year
  • Attend two scientific conferences, including presenting at the HVTN conference
  • Maximum award of $70,000

RAMP scholars are funded to travel to an HVTN clinical research site to conduct a project under the mentorship of an investigator.




HIV Vaccine Trial Experiences: Lessons for COVID-19 Vaccine Research and Acceptance (Location: Lilongwe, Malawi)

Understanding engagement to HIV prevention and sexual and reproductive health services among women after participating in a HIV vaccine trial (Location: Lilongwe, Malawi)

Prevalence and distribution of active sexually transmitted infections and bacterial vaginosis among symptomatic patients attending public health facilities in Soshanguve, South Africa (Location: Soshanguve, South Africa)

An investigation on the implications of VISP post HIV Vaccine Efficacy Trial participation in Zimbabwe (Location: Chitungwiza, Zimbabwe)

Risk perception, HIV prevention seeking behaviors and access to HIV prevention methods post HIV Vaccine Efficacy Trial participation (Location: Chitungwiza, Zimbabwe)


North America:

Characterizing undiagnosed and incident STIs an HIV vaccine cohort in South Africa (Location: Seattle, Washington, USA)

Stick2PrEP CisWomen/Trans Individuals (S2P: CWTI): Increasing Pre-Exposure Prophylaxis (PrEP) Uptake, Adherence, and Retention in Care, and Understanding PrEP Preferences Among Predominantly Black and Latinx Cisgender Women and Transgender Individuals (Location: New York, New York, USA)

The Role of the Microbiome in Rectal and Pharyngeal Sexually Transmitted Infections Amongst Men Who Have Sex with Men in a Comprehensive HIV Prevention Program (Location: New York, New York, USA)

Stick2PrEP 3.0 – Understanding Engagement in PrEP Care Among Individuals Receiving Sexual Health Services (Location: New York, New York, USA)

Evaluating the impact of expanded low risk behavior guidelines with PrEP use on recruitment of participants into HVTN Phase 1 studies (Location: New York, New York, USA)

Examining the influence of the COVID-19 pandemic on participation in Phase I HIV vaccine clinical studies among diverse populations in New York City: A social networks perspective (Location: New York, New York, USA)

Experiences and perceptions about accessing HIV prevention services and participating in HIV vaccine trials: The voices of Black men who have sex with men (BMSM) (Location: New York, New York, USA)


South America:

The Impact of Vaccination Against COVID-19 in Cases of Hospital Admissions and Deaths in Rio Grande do Sul (Location: Porto Alegre, Brazil)

Prevention Practices and Risk to Exposure to SARS-CoV-2 Infection in HIV Pre-Exposure Prophylaxis (Prep) Users (Location: Porto Alegre, Brazil)

To see projects of our current and former scholars, check out their profiles.


Who can apply?

The HVTN will be accepting up to 7 RAMP scholars who meet the following criteria:

  • Self-identify as African-American and/or Latinx
  • Student attending an accredited US medical school conferring MD and DO degrees
  • In good academic standing
  • US citizen or US permanent resident
  • Interested in pursuing a future career in HIV research


How to Apply

Please visit How To Apply.


For more information, please contact:

Linda Oseso, MPH
RAMP Program Manager
HIV Vaccine Trials Network

Fred Hutchinson Cancer Research Center
1100 Eastlake Ave., E3-300
Seattle, WA 98109-1024